Ignite Creation Date:
2024-05-06 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03647488
Status:
COMPLETED
Last Update Posted:
2022-01-24
First Post:
2018-08-20
Brief Title:
Study of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-26
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-20
First Submit QC Date:
August 23 2018
Study First Post Date:
2018-08-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-10-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-21
Last Update Post Date:
2022-01-24
Last Update Post Date Type:
ACTUAL